BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9330891)

  • 1. Gene therapy research for Duchenne and Becker muscular dystrophies.
    Karpati G; Gilbert R; Petrof BJ; Nalbantoglu J
    Curr Opin Neurol; 1997 Oct; 10(5):430-5. PubMed ID: 9330891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
    Song Y; Morales L; Malik AS; Mead AF; Greer CD; Mitchell MA; Petrov MT; Su LT; Choi ME; Rosenblum ST; Lu X; VanBelzen DJ; Krishnankutty RK; Balzer FJ; Loro E; French R; Propert KJ; Zhou S; Kozyak BW; Nghiem PP; Khurana TS; Kornegay JN; Stedman HH
    Nat Med; 2019 Oct; 25(10):1505-1511. PubMed ID: 31591596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles.
    Gilbert R; Nalbantoglu J; Petrof BJ; Ebihara S; Guibinga GH; Tinsley JM; Kamen A; Massie B; Davies KE; Karpati G
    Hum Gene Ther; 1999 May; 10(8):1299-310. PubMed ID: 10365661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
    Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
    Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?
    Wells DJ; Wells KE
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S11-22. PubMed ID: 12206790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene therapy to muscle diseases: perspective and issues on basic research].
    Takeda S
    Nihon Rinsho; 1997 Dec; 55(12):3114-9. PubMed ID: 9436420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to adenovirus-delivered antigens upregulates utrophin and results in mitigation of muscle pathology in mdx mice.
    Yamamoto K; Yuasa K; Miyagoe Y; Hosaka Y; Tsukita K; Yamamoto H; Nabeshima YI; Takeda S
    Hum Gene Ther; 2000 Mar; 11(5):669-80. PubMed ID: 10757347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin.
    Louboutin JP; Rouger K; Tinsley JM; Halldorson J; Wilson JM
    Mol Med; 2001 May; 7(5):355-64. PubMed ID: 11474581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.
    Tinsley JM; Potter AC; Phelps SR; Fisher R; Trickett JI; Davies KE
    Nature; 1996 Nov; 384(6607):349-53. PubMed ID: 8934518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functions of dystrophin and dystrophin associated proteins.
    Michalak M; Opas M
    Curr Opin Neurol; 1997 Oct; 10(5):436-42. PubMed ID: 9330892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient utrophin expression following adenovirus gene transfer in dystrophic muscle.
    Gilbert R; Nalbanoglu J; Tinsley JM; Massie B; Davies KE; Karpati G
    Biochem Biophys Res Commun; 1998 Jan; 242(1):244-7. PubMed ID: 9439643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of new therapy on muscular dystrophy].
    Takeda S
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1154-6. PubMed ID: 12235824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
    Perkins KJ; Davies KE
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S78-89. PubMed ID: 12206801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic and genetic therapy for childhood muscular dystrophies.
    Escolar DM; Scacheri CG
    Curr Neurol Neurosci Rep; 2001 Mar; 1(2):168-74. PubMed ID: 11898513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for muscular dystrophies: current status and future prospects.
    Takeda S; Miyagoe-Suzuki Y
    BioDrugs; 2001; 15(10):635-44. PubMed ID: 11604045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Utrophin, a way to cure Duchenne muscle dystrophy].
    Gillis JM
    Med Sci (Paris); 2004 Apr; 20(4):442-7. PubMed ID: 15124117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
    Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K
    Nat Med; 1998 Dec; 4(12):1441-4. PubMed ID: 9846586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Backup gene may help muscles help themselves.
    Roush W
    Science; 1997 Apr; 276(5309):35. PubMed ID: 9122707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.